NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma
AUTOR(ES)
Flockhart, R J
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2768445Documentos Relacionados
- Clinical significance of BRAF mutations in metastatic melanoma
- Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
- Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
- B-Raf specific antibody responses in melanoma patients
- Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice